MizenميزانTunis Stock Exchange — the daily briefing
Session of 09/10/2026 indices of 09/10/2026 Updated 09/10/2026 at 16:55

UMED: share price, dividend and results

UNITE DE FABRICATION DE MEDICAMENTS UMED

Health care · compartment A

Alert me on this stock
Price
8.770 TND
-0.11 % on the session · session of 09/10/2026 · quote feed, read at 16h15
Market capitalisation
281 MTND
32,000,000 shares
High
10.950 TND
on 17/07/2026
Low
6.180 TND
on 20/06/2024
Free-float capitalisation
84 MTND
30% free float — notice of 30/01/2026
Reservation band
8.250 – 9.290
group 11 · continuous · ±6% of the last price
2025 close
9.450
session of 31/12/2025
P/E
15.1
financial year 31/12/2025
Composite score
57.4
rank 17 of 48
Ordinary general meeting · 17/06/2026Ex-div 0.625 · 09/09/2026
15/05/2023low 6.180 · high 10.95009/10/2026

DividendMeeting

Performance

Computed from Tunis Stock Exchange quotations (818 sessions since 27/06/2023). annualised volatility 22.1% · beta 0.59 · maximum drawdown -20.9% · 52 weeks: 7.960 – 10.950

1 week-0.3 %
1 month-5.2 %
3 months-17.8 %
Year to date-7.2 %
1 year+3.8 %
3 years+13.3 %

Getting out

Rolling window of the last 120 market sessions, since 14/04/2026 (the Official Bulletin carries no per-security volumes: the measure does not go back before they were published). A session with no trade counts as zero — that is what a holder wanting to sell actually faced. This median also decides whether the security is ranked by the score.

Sessions traded120 of 120
Median volume per session167,455 TND
Selling out 50,000 TNDabout 2 sessions, at 25% of the median volume

Block trades

1 block trade(s) declared since 13/04/2026 — off-book, gap to the session close.

DateQuantityPriceVolume MTNDGap
13/04/20261,122,60010.00011.23+11.1 %

Financial ratios

Computed in-house from the financial statements for the year ended 31/12/2025, extracted from the PDF filed on the Tunis Stock Exchange website. Amounts in millions of dinars. Source :

Size and earnings
Shareholders' equitybefore appropriation116.5 M
Net income18.6 M
Total assets200.6 M
Per share
Earnings per share ?net income / listed shares0.581
Book value per share ?Shareholders' equity divided by the number of shares — what a share would be worth at the book value of the company's assets.3.642
Dividend per share ?financial year 20250.625
Valuation
P/E ?price / earnings per share15.1—
Price / book value ?2.41—
Premium / discount to book valueGap between price and book value. Positive means the market pays more than net assets; negative, less.141 %
Returns and payout
Return on equity ?16.0 %—
Return on assets ?9.3 %
Dividend yield ?at today's price7.13 %—
Payout ratio ?dividends / net income108 %

No median is published for this sector: fewer than five constituents carry the ratio.

Cite: Mizen, "UNITE DE FABRICATION DE MEDICAMENTS — Financial ratios", mizen.cloud/en/valeur/UMED#ratios, based on the documents linked above, accessed 09/10/2026.

Quarterly indicators

T3 2026 activity indicators: legal deadline 20/10/2026. Last year, filed on 17/10/2025.

Alert me on this stock

Revenue in thousands of dinars, extracted from the published activity indicators.

PeriodPeriod endRevenueYear-on-yearSource
T2 202630/06/202668,281-6.0 %
T1 202631/03/202630,941-7.0 %
T4 202531/12/202533,879-21.9 %
T3 202530/09/202538,628+1.4 %

Cite: Mizen, "UNITE DE FABRICATION DE MEDICAMENTS — Quarterly indicators", mizen.cloud/en/valeur/UMED#trimestres, based on the documents linked above, accessed 09/10/2026.

Composite score

57.4 / 100 — rank 17 of 48; measured factors: 100% of the model's weight. Each factor is a percentile rank among ranked securities. A known unfavourable fact (a loss, no dividend) takes the last rank; an unknown counts as 50 and does not appear in the bars (method and weights). An observational ranking, not investment advice.

Dividend yield96
Volatility84
Daily liquidity71
Return on equity66
P/E64
Revenue growth27
1 year16

Capital structure

Share capital, share count and free float, from the register of listed securities and the exchange index committee's notices.

Share capital32,000,000 DT
Shares outstanding32,000,000
Par value1.000 DT
Market capitalisation280.6 MDT (of which free float 84.2 MDT)
ISINTN0007720014
Listing compartmentA
Listed since28/04/2016
Free float 30.0 %Not in free float 70.0 %

notice no. 57 of 30/01/2026 · 32,000,000 shares outstanding

Capital ownership

From the Tunis Stock Exchange company profile, as at 17/06/2026.

ShareholderShares% of capital
Ridha Ben Ali CHARFEDDINE9,363,76529.26 %
PREMIUM HOLDING13,041,86540.76 %
Shareholders holding less than 5%9,594,37029.98 %
Total listed100.00 %

Cite: Mizen, "UNITE DE FABRICATION DE MEDICAMENTS — Capital structure", mizen.cloud/en/valeur/UMED#capital, based on the documents linked above, accessed 09/10/2026.

Filings

20 archived document(s); the 20 most recent. Links to the Tunis Stock Exchange PDFs.

See also

The session in your inbox

The free Mizen newsletter: the trend one hour after the open, then the state of the market after the close. An unsubscribe link in every letter.

You will only receive the letter after clicking the link in the confirmation email.